Danazol Treatment for Telomere Diseases
2016
BackgroundGenetic defects in telomere maintenance and repair cause bone marrow failure, liver cirrhosis, and pulmonary fibrosis, and they increase susceptibility to cancer. Historically, androgens have been useful as treatment for marrow failure syndromes. In tissue culture and animal models, sex hormones regulate expression of the telomerase gene. MethodsIn a phase 1–2 prospective study involving patients with telomere diseases, we administered the synthetic sex hormone danazol orally at a dose of 800 mg per day for a total of 24 months. The goal of treatment was the attenuation of accelerated telomere attrition, and the primary efficacy end point was a 20% reduction in the annual rate of telomere attrition measured at 24 months. The occurrence of toxic effects of treatment was the primary safety end point. Hematologic response to treatment at various time points was the secondary efficacy end point. ResultsAfter 27 patients were enrolled, the study was halted early, because telomere attrition was reduce...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
211
Citations
NaN
KQI